Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
泌淋胶囊 (Milin Capsule) is a traditional Chinese medicine (TCM) or Miao medicine in capsule form. It is composed of several herbal ingredients, including Sijihong (四季红, also known as Touhualiao), Plantago asiatica (车前草), Oxalis corniculata (酢浆草), and Shijiaocao (石椒草). The drug is indicated for the treatment of stranguria syndrome (淋证) caused by damp-heat accumulation, which manifests as difficult and painful urination, dripping urination, and urinary tract infections. It is also used for conditions such as prostatitis, acute non-specific urinary tract infections, cystitis, pyelonephritis, and urinary stones. Its mechanism of action, based on traditional Chinese medicine principles, involves clearing heat, detoxifying, promoting diuresis, and relieving stranguria. Pharmacological studies suggest that Milin Capsule possesses antibacterial, anti-inflammatory, immune-enhancing, and analgesic properties. It is manufactured by Guizhou Yibai Women's Pharmaceutical Co., Ltd. and is available as a prescription drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 泌淋胶囊.